General Information of Drug (ID: DMH89O5)

Drug Name
2-morpholino-1,1-di(pyridin-3-yl)hexan-1-ol
Synonyms CHEMBL1088803; 2-morpholino-1,1-di(pyridin-3-yl)hexan-1-ol; SCHEMBL1242083
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 341.4
Logarithm of the Partition Coefficient (xlogp) 1.9
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C20H27N3O2
IUPAC Name
2-morpholin-4-yl-1,1-dipyridin-3-ylhexan-1-ol
Canonical SMILES
CCCCC(C(C1=CN=CC=C1)(C2=CN=CC=C2)O)N3CCOCC3
InChI
InChI=1S/C20H27N3O2/c1-2-3-8-19(23-11-13-25-14-12-23)20(24,17-6-4-9-21-15-17)18-7-5-10-22-16-18/h4-7,9-10,15-16,19,24H,2-3,8,11-14H2,1H3
InChIKey
MHMGSQRAIMZTJJ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11588169
ChEBI ID
CHEMBL1088803
TTD ID
D0A5KP
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated potassium channel Kv1.5 (KCNA5) TTW0CMT KCNA5_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2493-6.